Bupropion/Nortriptyline Combination for Refractory Depression
Jeffrey Apter, Stuart Kushner, Robert L. Woolfolk
Abstract
Jeffrey Apter, Stuart Kushner, Robert L. Woolfolk
Abstract
Many patients fail to respond to one or more trials with a single antidepressant. In such cases polypharmacy is often necessary and beneficial, although there may be an increased risk of complications. Four case reports are presented of patients with refractory depression treated successfully with the combination of the tricyclic antidepressant nortriptyline and the newer agent bupropion.
OpenAlex reports 15 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Many patients fail to respond to one or more trials with a single antidepressant. In such cases polypharmacy is often necessary and beneficial, although there may be an increased risk of complications. Four case reports are presented of patients with refractory depression treated successfully with the combination of the tricyclic antidepressant nortriptyline and the newer agent bupropion.
Key concepts: Nortriptyline, Bupropion, Polypharmacy, Antidepressant, Tricyclic, Refractory (planetary science), Tricyclic antidepressant, Depression (economics)